New 2016 Publications from EXAMINE

Cardiovascular Effects of Incretin-Based Therapies.
White WB, Baker WL. Annu Rev Med. 2016;67:245-60. doi: 10.1146/annurev-med-050214-013431. Review. PMID: 26768240

Angiotensin-Converting Enzyme Inhibitor Use and Major Cardiovascular Outcomes in Type 2 Diabetes Mellitus Treated With the Dipeptidyl Peptidase 4 Inhibitor Alogliptin.
White WB, Wilson CA, Bakris GL, Bergenstal RM, Cannon CP, Cushman WC, Heller SK, Mehta CR, Nissen SE, Zannad F, Kupfer S; EXAMINE Investigators. Hypertension. 2016 Sep;68(3):606-13. doi: 10.1161/HYPERTENSIONAHA.116.07797. Epub 2016 Aug 1. PMID: 27480840

Relationship of Glycated Haemoglobin and Reported Hypoglycaemia to Cardiovascular Outcomes in Patients with Type 2 Diabetes and Recent Acute Coronary Syndrome Events: The EXAMINE Trial

Ischemic Cardiac Outcomes and Hospitalizations According to Prior Macrovascular Disease Status in Patients with Type 2 Diabetes and Recent Acute Coronary Syndrome from the Examination of Cardiovascular Outcomes with Alogliptin Versus Standard of Care Trial

Cardiovascular Mortality in Patients with Type 2 Diabetes and Recent Acute Coronary Syndromes from the EXAMINE Trial